RadNet completed the acquisition of Aidence Holding and Quantib.

RadNet, a radiology firm, completed the acquisition of medical diagnostic services providers Aidence Holding and Quantib. Financial terms were not disclosed. “We remain convinced that artificial intelligence will have a transforming impact on diagnostic imaging and the field of radiology. We are very pleased to expand our portfolio of AI software into two other cancer screening domains. With the addition of Aidence and Quantib, we will now have effective screening solutions for the three most prevalent cancers. We believe that large population health screening will play an important role for health insurers, health systems and large employer groups in the near future. As the largest owner of diagnostic imaging centers in the United States, RadNet has relationships that can serve to make large-scale screening programs, similar to what mammography is for breast cancer screening, a reality," Howard Berger, RadNet Chairman and CEO.